Pharmafile Logo
Pharmafocus logo
Advanced Search

aHUS

Showing 4 posts of 4 posts found.

Soliris image

NICE approves world’s most expensive drug

January 28, 2015
Sales and Marketing Alexion, Dillon, NHS, NICE, aHUS, eculizumab, hst, soliris

The world’s most expensive drug has been approved in final guidance from NICE, making it the first drug to pass …

News
Soliris image

NHS to get world’s most expensive drug

November 27, 2014
Sales and Marketing Alexion, NICE, aHUS, beauchamp, blood, eculizumab, soliris

UK health watchdog NICE has recommended Alexion’s Soliris for patients with the rare disease atypical haemolytic uremic syndrome (aHUS).  Soliris …

News
Solaris image

NICE backs world’s most expensive medicine

September 4, 2014
Sales and Marketing AGNSS, Alexion, England, NICE, aHUS, solaris

In a U-turn on its previous guidance NICE is now recommending that the £330,000 rare disease drug Soliris should be …

News
Soliris image

Alexion ‘concerned’ over NICE draft

March 4, 2014
Sales and Marketing NICE, aHUS, alexia, blood, eculizumab, soliris

Alexion Pharmaceuticals UK has expressed ‘concern’ that NICE has not yet allowed its rare disease treatment Soliris to be formally …

News

Latest content

AbbVie invests €150m in new R&D facility in Germany

May 3, 2024

AstraZeneca shares positive interim results from phase 3 lymphoma trial

May 3, 2024

Merck shares data from phase 3 trial of Keytruda for gastric cancers

May 2, 2024

Verona Pharma to share phase 3 COPD trial data at ATS 2024

May 2, 2024

Beckman Coulter Life Sciences and Watchmaker Genomics enter collaboration

May 1, 2024